Acute Rhabdomyolysis Following Synthetic Cannabinoid Use in a 16-Year-Old Patient: A Case Report

Rhabdomyolysis, characterized by the breakdown of skeletal muscle, can lead to severe complications such as acute kidney injury (AKI). This case report describes a 16-year-old female who developed severe rhabdomyolysis without renal impairment following synthetic cannabinoid (K2) use. Presenting with muscle weakness, dark urine, and metabolic acidosis, the patient responded well to aggressive fluid resuscitation. This case serves as a reminder for healthcare professionals to consider synthetic cannabinoids as a possible cause of rhabdomyolysis, even when renal function appears preserved, emphasizing the importance of early intervention to prevent complications.